 Further studies are needed to translate these mouse studies to humans.Increased expression of cyclooxygenases and their potential involvement in the progression of various human cancers have been described.Some studies suggest that the TXA2 downstream metabolite of these cyclooxygenases along with its TP receptor contribute to mediating this progression.